Cris Olsen

482 total citations
12 papers, 404 citations indexed

About

Cris Olsen is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Cris Olsen has authored 12 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Cris Olsen's work include Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (8 papers) and Pain Mechanisms and Treatments (4 papers). Cris Olsen is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Neuropeptides and Animal Physiology (8 papers) and Pain Mechanisms and Treatments (4 papers). Cris Olsen collaborates with scholars based in United States. Cris Olsen's co-authors include Lawrence Toll, Willma E. Polgar, Nurulain T. Zaveri, Faming Jiang, Taline V. Khroyan, Juan Orduña, Damon A. Parrish, Jeffrey R. Deschamps, Ronald G. Almquist and Edward T. Uyeno and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Cris Olsen

12 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cris Olsen United States 10 301 270 130 78 15 12 404
Ken Meecham United Kingdom 8 255 0.8× 238 0.9× 73 0.6× 88 1.1× 15 1.0× 14 397
Irena Berezowska Canada 13 550 1.8× 448 1.7× 92 0.7× 61 0.8× 19 1.3× 21 637
Katarzyna Sobczyk‐Kojiro United States 14 420 1.4× 370 1.4× 111 0.9× 56 0.7× 14 0.9× 18 560
Grazyna Ciszewska United States 7 155 0.5× 177 0.7× 154 1.2× 75 1.0× 14 0.9× 10 337
Timothy A. True United States 9 350 1.2× 190 0.7× 140 1.1× 46 0.6× 32 2.1× 12 475
Scott B. Hoyt United States 9 211 0.7× 92 0.3× 104 0.8× 106 1.4× 18 1.2× 15 353
Tod Steinfeld United States 12 173 0.6× 94 0.3× 167 1.3× 55 0.7× 25 1.7× 19 408
Toyokazu Hiranuma Japan 13 274 0.9× 248 0.9× 98 0.8× 110 1.4× 31 2.1× 26 504
Frank L. Wagenaar United States 12 137 0.5× 110 0.4× 100 0.8× 66 0.8× 11 0.7× 15 318
Awilda Stapelfeld United States 11 261 0.9× 227 0.8× 103 0.8× 167 2.1× 85 5.7× 13 504

Countries citing papers authored by Cris Olsen

Since Specialization
Citations

This map shows the geographic impact of Cris Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cris Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cris Olsen more than expected).

Fields of papers citing papers by Cris Olsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cris Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cris Olsen. The network helps show where Cris Olsen may publish in the future.

Co-authorship network of co-authors of Cris Olsen

This figure shows the co-authorship network connecting the top 25 collaborators of Cris Olsen. A scholar is included among the top collaborators of Cris Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cris Olsen. Cris Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zaveri, Nurulain T., Faming Jiang, Cris Olsen, Willma E. Polgar, & Lawrence Toll. (2013). Designing bifunctional NOP receptor–mu opioid receptor ligands from NOP receptor-selective scaffolds. Part I.. Bioorganic & Medicinal Chemistry Letters. 23(11). 3308–3313. 36 indexed citations
2.
Zaveri, Nurulain T., Faming Jiang, Cris Olsen, Willma E. Polgar, & Lawrence Toll. (2010). Novel α3β4 Nicotinic Acetylcholine Receptor-Selective Ligands. Discovery, Structure−Activity Studies, and Pharmacological Evaluation. Journal of Medicinal Chemistry. 53(22). 8187–8191. 45 indexed citations
3.
Toll, Lawrence, Taline V. Khroyan, Willma E. Polgar, et al.. (2009). Comparison of the Antinociceptive and Antirewarding Profiles of Novel Bifunctional Nociceptin Receptor/μ-Opioid Receptor Ligands: Implications for Therapeutic Applications. Journal of Pharmacology and Experimental Therapeutics. 331(3). 954–964. 70 indexed citations
4.
Khroyan, Taline V., Willma E. Polgar, Juan Orduña, et al.. (2009). Activity of new NOP receptor ligands in a rat peripheral mononeuropathy model: Potentiation of morphine anti-allodynic activity by NOP receptor antagonists. European Journal of Pharmacology. 610(1-3). 49–54. 13 indexed citations
5.
Khroyan, Taline V., Nurulain T. Zaveri, Willma E. Polgar, et al.. (2006). SR 16435 [1-(1-(Bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a Novel Mixed Nociceptin/Orphanin FQ/μ-Opioid Receptor Partial Agonist: Analgesic and Rewarding Properties in Mice. Journal of Pharmacology and Experimental Therapeutics. 320(2). 934–943. 58 indexed citations
6.
Zaveri, Nurulain T., Faming Jiang, Cris Olsen, Willma E. Polgar, & Lawrence Toll. (2005). Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP. The AAPS Journal. 7(2). E345–E352. 49 indexed citations
7.
Zaveri, Nurulain T., Faming Jiang, Cris Olsen, et al.. (2004). A Novel Series of Piperidin-4-yl-1,3-Dihydroindol-2-ones as Agonist and Antagonist Ligands at the Nociceptin Receptor. Journal of Medicinal Chemistry. 47(12). 2973–2976. 66 indexed citations
8.
Velaparthi, Upender, Daniel J. Pollart, Peter D. Hobbs, et al.. (1996). The synthesis and biological activity of two analogs of the anti‐HIV alkaloid michellamine B. Journal of Heterocyclic Chemistry. 33(4). 1371–1384. 25 indexed citations
9.
Toll, Lawrence, et al.. (1991). Isolation and characterization of a new atrial peptide-degrading enzyme from bovine kidney. Biochemical and Biophysical Research Communications. 175(3). 886–893. 16 indexed citations
10.
Johnson, Paul H., Ping Sze, Richard C. Winant, et al.. (1991). Structure-Function and Refolding Studies of the Thrombin-Specific Inhibitor Hirudin. Pathophysiology of Haemostasis and Thrombosis. 21(Suppl. 1). 41–48. 5 indexed citations
11.
Lawson, John A., Cris Olsen, Lawrence Toll, et al.. (1987). Novel μ‐selective Met‐enkephalinamide analogs with antagonist activity.. International journal of peptide & protein research. 30(3). 299–317. 3 indexed citations
12.
Almquist, Ronald G., Cris Olsen, Edward T. Uyeno, & Lawrence Toll. (1984). Replacement of the peptide-backbone amides connecting Tyr-Gly and Gly-Gly in leucine-enkephalin with ketomethylene groups: synthesis and biological activity. Journal of Medicinal Chemistry. 27(2). 115–120. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026